Wir verwenden Cookies und Analyse-Tools, um die Nutzerfreundlichkeit der Internet-Seite zu verbessern und für Marketingzwecke. Wenn Sie fortfahren, diese Seite zu verwenden, nehmen wir an, dass Sie damit einverstanden sind. Zur Datenschutzerklärung.
Novel Therapeutics for Rare Lymphomas
Details
This comprehensive volume reviews the clinical presentation, diagnosis, and treatment approach to rare lymphomas. There is particular emphasis placed on new diagnostic approaches, novel chemotherapy combinations, and treatment modalities with novel therapeutics. It highlights research advances in a group of diseases that are often overlooked, and serves as a single repository of information on the most recent advances in targeted small molecule inhibitors, monoclonal antibodies, immunotherapy, and CAR-T therapy as they pertain to rare types of lymphoma. Written for practicing oncologists, hematologists, fellows, and residents, Novel Therapeutics for Rare Lymphomas covers rare subtypes of lymphoma, including indolent and aggressive T-cell lymphomas and B-cell lymphomas.
Discusses the clinical presentation, diagnosis, and treatment approach to rare lymphomas Focuses on new diagnostic approaches, novel chemotherapy combinations, and new treatment modalities with novel therapeutics Written for practicing oncologists, hematologists, fellows, and residents Covers T-cell Lymphomas, B-cell Lymphomas, Indolent/Aggressive, and Aggressive/Highly Aggressive types of Lymphomas
Autorentext
Christopher Dittus, DO, MPH
Assistant Professor of Medicine Division of Hematology/Oncology, Lymphoma Program
University of North Carolina, Chapel Hill
Inhalt
The Hematopathology and Diagnostic Challenges of Rare Lymphomas.- Novel Therapeutics in the Management of Waldenstrom Macroglobulinemia.- Immunotherapy in Hodgkin Lymphoma and other CD30+ Lymphomas.- Chronic Lymphocytic Leukemia with Alterations in TP53.- Mantel Cell Lymphoma.- Current and Emerging Treatment Strategies from Primary Mediastinal B-Cell Lymphoma.- Plasmablastic Lymphoma and Primary Effusion Lymphoma.- Novel Agents in Primary Central Nervous System Lymphoma.- Adult T-Cell Leukemia/Lymphoma.- Extranodal NK/T-Cell Lymphoma.- Anaplastic Large Cell Lymphoma.- Enteropathy-Associated T-Cell Lymphomas.- Hepatosplenic T-Cell Lymphoma.- Cutaneous T-Cell Lymphoma: Mycosis Fungoides and Sezary Syndrom.
Weitere Informationen
- Allgemeine Informationen
- Sprache Englisch
- Editor Christopher Dittus
- Titel Novel Therapeutics for Rare Lymphomas
- Veröffentlichung 24.10.2020
- ISBN 303025612X
- Format Kartonierter Einband
- EAN 9783030256128
- Jahr 2020
- Größe H235mm x B155mm x T14mm
- Gewicht 461g
- Auflage 1st edition 2020
- Genre Medizin
- Lesemotiv Verstehen
- Anzahl Seiten 264
- Herausgeber Springer International Publishing
- GTIN 09783030256128